General Information of This Drug (ID: DMG0SWE)

Drug Name
NBF-006   DMG0SWE
Drug Type
Small interfering RNA

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Colorectal cancer DISNH7P9 2B91.Z Phase 1 [1]
Pancreatic cancer DISJC981 2C10 Phase 1 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03819387) A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer. U.S. National Institutes of Health.